The Effect of Calcium-Vitamin D in Efficacy of Induction Ovulation in Infertile Women with Polycystic Ovary Syndrome

Document Type : Original Article

Authors

1 Assistant Professor of Obstetrics and Gynecology, Faculty of Medicine, Kordestan University of Medical Sciences, Kordestan, Iran.

2 Community Medicine Specialist, Faculty of Medicine, Kordestan University of Medical Sciences, Kordestan, Iran.

3 Resident of Obstetrics and Gynecology, Faculty of Medicine, Kordestan University of Medical Sciences, Kordestan, Iran.

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is one of the most common hormonal problems among women in the age of fertility that causes infertility via stopping ovulation. Prescribing calcium with clomiphene may greatly impact induction ovulation and follicles growth. Thus, this study was conducted aimed on investigating the effect of Calcium-vitamin D in efficacy of induction ovulation in infertile women with PCOS.
Methods: This randomized controlled trial was conducted on 44 infertile women with PCOS in years 2010-2011. Patients were divided into two groups (22 Intervention and 22 controls) using block randomization method. Intervention group received a daily dose of 50 mg clomiphene tablet with 400 units of vitamin D3 and 1000 mg calcium and control group received a daily dose of 50 mg clomiphene tablet with placebo. In order to measure follicles size, patients underwent sonography during three menstruation cycles, each time at 13th day of menstruation. Data were analyzed using SPSS software version 11.5 and Chi square, Fisher, Mann-Whitney and repeated measures ANOVA Tests. P less than 0.05 was considered statistically significant.
Results: No significant statistical different was observed in trend of changes in follicle size in two groups (p=0.1). However, the median and mean of follicles size in intervention group was higher than control group in first, second and third months (p<0.05). There was also no significant statistical difference between the first and second months regarding the size of follicles (p=0.82); but the size of follicles in third month was significantly different from second month (p=0.01).
Conclusion: Adding 400 units of vitamin D3 and 1000 mg calcium to normal clomiphene dosage may increase the size of follicles that its effect is especially more significant after the second post-treatment menstruation.

Keywords

References

1. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011 Feb
8;3:25-35.
2. Cheang KI, Huszar JM, Best AM, Sharma S, Essah PA, Nestler JE. Long-term effect of metformin on metabolic
parameters in the polycystic ovary syndrome. Diab Vasc Dis Res 2009 Apr;6(2):110-9. 3. Radosh L. Drug treatments for polycystic ovary syndrome. Am Fam Physician 2009 Apr 15;79(8):671-6. 4. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005 Mar 24;352(12):1223-36. Review.
5. Prapas N, Karkanaki A, Prapas I, Kalogiannidis I, Katsikis I, Panidis D. Genetics of polycystic ovary syndrome.
Hippokratia 2009 Oct;13(4):216-23. 6. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M et al. Metformin effects on clinical features,
endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double- blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol
Metab 2000 Jan;85(1):139-46. 7. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and
diagnosis. Nat Rev Endocrinol 2011 Apr;7(4):219-31. 8. Giallauria F, Palomba S, Vigorito C, Tafuri MG, Colao A, Lombardi G et al. Androgens in polycystic ovary
syndrome: the role of exercise and diet .Semin Reprod Med 2009 Jul;27(4):306-15. 9. Overbeek A, Lambalk N. Pharmacogenomics of ovulation induction: facilitating decisions on who, when and
how to treat. Pharmacogenomics 2009 Sep;10(9):1377-9. 10. Balen AH, Rutherford AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ 2007 Sep
29;335(7621):663-6. 11. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in
the polycystic ovarian syndrome. Steroids 1999 Jun;64(6):430-5. 12. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in
polycystic ovary syndrome. Fertil Steril 2009 Sep;92(3):1053-8. 13. Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T et al. Prospective parallel randomized, double- blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line
treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin
Endocrinol Metab 2005 Jul;90(7):4068-74. 14. Siebert TI, Kruger TF, Lombard C. Evaluating the equivalence of clomiphene citrate with and without
metformin in ovulation induction in PCOS patients. J Assist Reprod Genet 2009 Apr;26(4):165-71. 15. Horng SG, Wang TH, Wang HS. Estradiol-to-testosterone ratio is associated with response to metformin
treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Chang Gung Med J
2008 Sep-Oct;31(5):477-83. 16. Nazari T, Bayat R, Samiei H. Effect of Metformin on single girl with polycystic ovarian syndrome. J Reprod
Infertil 2005 Apr-Jun;6(2):177-86. 17. Seifi F, Mehdizadeh A, Alavi S. [Comparison of efficacy of letrozole and clomiphene citrate in the treatment of
infertility induced by ovulation disorder in patients with polycystic ovarian syndrome] [Article in Persian. J
Islam Azad Uni Med Sci 2010;20(2):108-12. 18. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA et al. Clomiphene, metformin, or both
for infertility in the polycystic ovary syndrome. N Engl J Med 2007 Feb 8;356(6):551-66.
19. Rashidi B, Haghollahi F, Tehranian N, Shariat M, Zayerii F, Bagheri M et al. Therapeutic effects of vitamin D
and calcium in patients with polycystic ovary syndrome. J Reprod Infertil 2006;7(3):225-33. 20. Fica S, Albu A, Constantin M, Dobri GA. Insulin resistance and fertility in polycystic ovary syndrome. J Med
Life 2008 Oct-Dec;1(4):415-22.
21. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and
diagnosis. Nat Rev Endocrinol 2011 Apr;7(4):219-31.
 
22. Racowsky C. The releasing action of calcium upon cyclic AMP-dependent meiotic arrest in hamster oocytes. J
Exp Zool 1986 Aug;239(2):263-75. 23. Homa ST, Carroll J, Swann K. The role of calcium in mammalian oocyte maturation and egg activation. Hum
Reprod 1993 Aug;8(8):1274-81. Review.
24. Toth S, Huneau D, Banrezes B, Ozil JP. Egg activation is the result of calcium signal summation in the mouse.
Reproduction 2006 Jan;131(1):27-34. 25. Halloran BP, DeLuca HF. Vitamin D deficiency and reproduction in rats. Science 1979 Apr 6;204(4388):73-4. 26. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG et al. Serum 25-hydroxyvitamin D
concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009
Oct;280(4):559-63.

Files

Share

How to cite

Statistics